151 related articles for article (PubMed ID: 9582014)
1. In B16 melanoma cells, the inhibition of melanogenesis by TPA results from PKC activation and diminution of microphthalmia binding to the M-box of the tyrosinase promoter.
Bertolotto C; Bille K; Ortonne JP; Ballotti R
Oncogene; 1998 Apr; 16(13):1665-70. PubMed ID: 9582014
[TBL] [Abstract][Full Text] [Related]
2. Characterization of density-dependent regulation of the tyrosinase gene promoter: role of protein kinase C.
Mahalingam H; Watanabe A; Tachibana M; Niles RM
Exp Cell Res; 1997 Nov; 237(1):83-92. PubMed ID: 9417870
[TBL] [Abstract][Full Text] [Related]
3. TFE3, a transcription factor homologous to microphthalmia, is a potential transcriptional activator of tyrosinase and TyrpI genes.
Verastegui C; Bertolotto C; Bille K; Abbe P; Ortonne JP; Ballotti R
Mol Endocrinol; 2000 Mar; 14(3):449-56. PubMed ID: 10707962
[TBL] [Abstract][Full Text] [Related]
4. Regulation of tyrosinase gene expression by cAMP in B16 melanoma cells involves two CATGTG motifs surrounding the TATA box: implication of the microphthalmia gene product.
Bertolotto C; Bille K; Ortonne JP; Ballotti R
J Cell Biol; 1996 Aug; 134(3):747-55. PubMed ID: 8707852
[TBL] [Abstract][Full Text] [Related]
5. Role of microphthalmia transcription factor in regulation of melanocyte differentiation marker TRP-1.
Fang D; Setaluri V
Biochem Biophys Res Commun; 1999 Mar; 256(3):657-63. PubMed ID: 10080955
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor alpha-mediated inhibition of melanogenesis is dependent on nuclear factor kappa B activation.
Englaro W; Bahadoran P; Bertolotto C; Buscà R; Dérijard B; Livolsi A; Peyron JF; Ortonne JP; Ballotti R
Oncogene; 1999 Feb; 18(8):1553-9. PubMed ID: 10102625
[TBL] [Abstract][Full Text] [Related]
7. Regulation of melanogenesis in B16 mouse melanoma cells by protein kinase C.
Mahalingam H; Vaughn J; Novotny J; Gruber JR; Niles RM
J Cell Physiol; 1996 Sep; 168(3):549-58. PubMed ID: 8816909
[TBL] [Abstract][Full Text] [Related]
8. Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: pivotal role of M boxes (GTCATGTGCT) and of microphthalmia.
Bertolotto C; Buscà R; Abbe P; Bille K; Aberdam E; Ortonne JP; Ballotti R
Mol Cell Biol; 1998 Feb; 18(2):694-702. PubMed ID: 9447965
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of melanogenesis inhibition by 2,5-dimethyl-4-hydroxy-3(2H)-furanone.
Lee J; Jung E; Lee J; Huh S; Boo YC; Hyun CG; Kim YS; Park D
Br J Dermatol; 2007 Aug; 157(2):242-8. PubMed ID: 17650175
[TBL] [Abstract][Full Text] [Related]
10. Guggulsterone inhibits melanogenesis in B16 murine melanoma cells by downregulating tyrosinase expression.
Koo JH; Rhee KS; Koh HW; Jang HY; Park BH; Park JW
Int J Mol Med; 2012 Oct; 30(4):974-8. PubMed ID: 22797252
[TBL] [Abstract][Full Text] [Related]
11. Microphthalmia associated transcription factor is a target of the phosphatidylinositol-3-kinase pathway.
Khaled M; Larribere L; Bille K; Ortonne JP; Ballotti R; Bertolotto C
J Invest Dermatol; 2003 Oct; 121(4):831-6. PubMed ID: 14632202
[TBL] [Abstract][Full Text] [Related]
12. 2, 3, 5, 4'-tetrahydroxystilbene-2-O-beta-D-glucoside (THSG) induces melanogenesis in B16 cells by MAP kinase activation and tyrosinase upregulation.
Jiang Z; Xu J; Long M; Tu Z; Yang G; He G
Life Sci; 2009 Aug; 85(9-10):345-50. PubMed ID: 19527735
[TBL] [Abstract][Full Text] [Related]
13. Effect of pyrroloquinoline quinone (PQQ) on melanogenic protein expression in murine B16 melanoma.
Sato K; Toriyama M
J Dermatol Sci; 2009 Feb; 53(2):140-5. PubMed ID: 19013771
[TBL] [Abstract][Full Text] [Related]
14. Mangosteen leaf extract increases melanogenesis in B16F1 melanoma cells by stimulating tyrosinase activity in vitro and by up-regulating tyrosinase gene expression.
Hamid MA; Sarmidi MR; Park CS
Int J Mol Med; 2012 Feb; 29(2):209-17. PubMed ID: 22089762
[TBL] [Abstract][Full Text] [Related]
15. A novel adamantyl benzylbenzamide derivative, AP736, suppresses melanogenesis through the inhibition of cAMP-PKA-CREB-activated microphthalmia-associated transcription factor and tyrosinase expression.
Lee CS; Jang WH; Park M; Jung K; Baek HS; Joo YH; Park YH; Lim KM
Exp Dermatol; 2013 Nov; 22(11):762-4. PubMed ID: 24107097
[TBL] [Abstract][Full Text] [Related]
16. Effect of Angelica gigas extract on melanogenesis in B16 melanoma cells.
Lv N; Koo JH; Yoon HY; Yu J; Kim KA; Choi IW; Kwon KB; Kwon KS; Kim HU; Park JW; Park BH
Int J Mol Med; 2007 Nov; 20(5):763-7. PubMed ID: 17912471
[TBL] [Abstract][Full Text] [Related]
17. NDRG2 gene expression in B16F10 melanoma cells restrains melanogenesis via inhibition of Mitf expression.
Kim A; Yang Y; Lee MS; Yoo YD; Lee HG; Lim JS
Pigment Cell Melanoma Res; 2008 Dec; 21(6):653-64. PubMed ID: 19067970
[TBL] [Abstract][Full Text] [Related]
18. Hirseins inhibit melanogenesis by regulating the gene expressions of Mitf and melanogenesis enzymes.
Villareal MO; Han J; Yamada P; Shigemori H; Isoda H
Exp Dermatol; 2010 May; 19(5):450-7. PubMed ID: 19765058
[TBL] [Abstract][Full Text] [Related]
19. Sesamin induces melanogenesis by microphthalmia-associated transcription factor and tyrosinase up-regulation via cAMP signaling pathway.
Jiang Z; Li S; Liu Y; Deng P; Huang J; He G
Acta Biochim Biophys Sin (Shanghai); 2011 Oct; 43(10):763-70. PubMed ID: 21896570
[TBL] [Abstract][Full Text] [Related]
20. A derivative of 2-aminothiazole inhibits melanogenesis in B16 mouse melanoma cells via glycogen synthase kinase 3β phosphorylation.
Kim SY; Hahn HG; Nam KD; Park KC; Yun HY; Baek KJ; Kwon NS; Kim DS
J Pharm Pharmacol; 2011 Aug; 63(8):1031-6. PubMed ID: 21718286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
